Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
23.15
-0.37 (-1.57%)
At close: Jun 27, 2025, 4:00 PM
24.07
+0.92 (3.97%)
After-hours: Jun 27, 2025, 7:30 PM EDT
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $1.37 billion as of June 27, 2025. Its market cap has decreased by -39.09% in one year.
Market Cap
1.37B
Enterprise Value
378.37M
1-Year Change
-39.09%
Ranking
Category
Stock Price
$23.15
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $1.37B, an increase of 123.21%. That is a compound annual growth rate of 21.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 1.39B | -54.91% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 712.62B |
| Johnson & Johnson | 366.44B |
| AbbVie | 331.32B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 276.23B |
| Abbott Laboratories | 235.02B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |